Need professional-grade analysis? Visit stockanalysis.com
$1.02B
13.61
71
6.61%
Vistin Pharma ASA (VISTN) trades on Oslo Stock Exchange in NOK. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at NOK22.80, down 0.87% from the previous close.
Over the past year, VISTN has traded between a low of NOK19.70 and a high of NOK25.30. The stock has lost 0.2% over this period. It is currently 9.9% below its 52-week high.
Vistin Pharma ASA has a market capitalization of $1.02B, with a price-to-earnings ratio of 13.61 and a dividend yield of 6.61%.
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.
Side-by-side comparison against top Healthcare peers.